Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash and Bank

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash and Bank ₹1,176 Cr₹1,705 Cr₹1,659 Cr₹1,160 Cr₹1,412 Cr

What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS is ₹1,176 Cr based on Mar2026 Consolidated results.
Year Cash and Bank
Mar2026₹1,176 Cr
Mar2025₹1,705 Cr
Mar2024₹1,659 Cr
Mar2023₹1,160 Cr
Mar2022₹1,412 Cr

How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?

Years Cash and Bank % Change
Mar2026 ₹1,176 Cr
-31.02
Mar2025 ₹1,705 Cr
2.76
Mar2024 ₹1,659 Cr
43.02
Mar2023 ₹1,160 Cr
-17.80
Mar2022 ₹1,412 Cr -

Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,333.7 Cr -2.6% -8.5% 16.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.6%

-8.5%

16.4%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses